Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.88 USD | +0.66% | +4.56% | -40.29% |
Apr. 15 | RBC Lowers Price Target on Nevro to $16 From $18, Keeps Sector Perform Rating | MT |
Apr. 11 | Mizuho Adjusts Price Target on Nevro to $16 From $20, Maintains Neutral Rating | MT |
Evolution of the average Target Price on Nevro Corp.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Nevro Corp.
RBC Capital Markets | |
Mizuho Securities | |
Citigroup | |
Wells Fargo Securities | |
Baird | |
Oppenheimer | |
Truist Securities | |
Canaccord Genuity | |
Morgan Stanley | |
BofA Securities | |
JMP Securities | |
JPMorgan Chase | |
Piper Sandler | |
Jefferies & Co. | |
Wolfe Research | |
SVB Leerink | |
UBS | |
OTR Global | |
William Blair & Co. | |
Redburn |
EPS Revisions
- Stock Market
- Equities
- NVRO Stock
- Consensus Nevro Corp.